Listed

Ernexa Therapeutics Inc.

ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31

Reports and events: 422 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Ernexa Therapeutics Inc., Reports and events
FiledFormWhat it isAccession number
2017-04-2816:30 ETDEF 14AProxy statementPeriod 2017-04-280001493152-17-004542
2017-04-2516:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-17-004370
2017-04-1216:30 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-17-003784
2017-03-3116:10 ETSC 13D/AOwnership report, active investor, amended0001493152-17-003215
2017-03-3116:05 ET8-K8.01 Other events0001493152-17-003210
2017-03-2716:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-17-002865
2017-03-1510:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-17-002443
2017-03-1418:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-17-002389
2017-03-0913:01 ET10-KAnnual reportPeriod 2016-12-310001493152-17-002280
2017-03-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-17-002144
2017-03-0316:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-17-002117
2017-01-0416:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-17-000123
2016-12-0713:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-015718
2016-11-1511:17 ETSC 13D/AOwnership report, active investor, amended0001493152-16-015035
2016-11-0917:24 ET10-QQuarterly reportPeriod 2016-09-300001493152-16-014680
2016-11-0816:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-16-014616
2016-11-0416:30 ET8-K8.01 Other events0001493152-16-014519
2016-11-0109:08 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-014394
2016-09-0708:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-013154
2016-08-0414:23 ET10-QQuarterly reportPeriod 2016-06-300001493152-16-011963
2016-08-0316:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-16-011925
2016-06-1708:01 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-010919
2016-06-0708:35 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-010575
2016-05-1208:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-009668
2016-05-0916:43 ET10-QQuarterly reportPeriod 2016-03-310001493152-16-009551
2016-05-0608:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-16-009466
2016-04-2216:31 ETDEF 14AProxy statementPeriod 2016-04-220001493152-16-009130
2016-04-1316:30 ET8-K3.01 Delisting notice0001493152-16-008859
2016-03-1611:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-16-008073
2016-03-1513:02 ET10-KAnnual reportPeriod 2015-12-310001493152-16-008049
2016-03-1417:10 ET8-K/A1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-16-008030
2016-03-1117:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-16-008002
2016-03-1107:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-16-007971
2016-02-2916:41 ET8-K5.02 Departure or appointment of officers or directors0001493152-16-007725
2016-02-1108:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001019687-16-005125
2016-02-0207:15 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001019687-16-004980
2016-01-2816:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001019687-16-004954
2016-01-2216:30 ET8-K5.02 Departure or appointment of officers or directors0001019687-16-004913
2015-12-0215:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001019687-15-004396
2015-11-1719:05 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001019687-15-004169
2015-11-0917:03 ET10-QQuarterly reportPeriod 2015-09-300001019687-15-003962
2015-11-0516:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001019687-15-003924
2015-08-1014:57 ET10-QQuarterly reportPeriod 2015-06-300001019687-15-003021
2015-08-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001019687-15-002970
2015-06-0816:58 ET8-K5.07 Shareholder vote results0001019687-15-002326
2015-05-1416:26 ET8-K5.02 Departure or appointment of officers or directors0001019687-15-001942
2015-05-0815:11 ET10-QQuarterly reportPeriod 2015-03-310001019687-15-001815
2015-05-0716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001019687-15-001796
2015-04-2416:45 ETDEF 14AProxy statementPeriod 2015-06-050001019687-15-001600
2015-04-2016:45 ET8-K5.02 Departure or appointment of officers or directors0001019687-15-001550

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.